Cancer

The 2025 American Society of Clinical Oncology Annual (ASCO) Meeting was held in Chicago, Illinois, May 30-June 3. Many Rogel researchers participated in presentations, poster sessions and panel discussions before an audience of cancer researchers from around the globe. Read on for the highlights.

Cancer antigen-encoding RNA vaccines, or circRNA, is a targeted technology that improves existing immunotherapy and vaccine approaches

A revolutionary new therapy, called histotripsy uses soundwaves to destroy liver tumors and was approved for clinical use by the FDA in 2023. A recent study in the journal Cancers demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.

Researchers say the technology could one day be applied to other cancers

Novel finding suggests a possible target for improving response to immune-based cancer treatments

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy

Authors account for both verbal and nonverbal communication among doctors, medical staff and cancer patients